FOXO3 and colorectal carcinoma: These studies revealed that p38α blockade inhibits CRC cancerogenesis by inducing a transcriptional switch from HIF1α- to FoxO3A-dependent gene expression, resulting in a shift from glycolysis genes to genes involved in fatty acid catabolism and protection against stress conditions [97,100,101].